XML 80 R56.htm IDEA: XBRL DOCUMENT v3.3.0.814
Borrowings (Tables)
9 Months Ended 12 Months Ended
Sep. 30, 2015
Dec. 31, 2014
Debt Disclosure [Abstract]    
Schedule of Match Funded Liabilities
Match funded liabilities are comprised of the following at the dates indicated:
Borrowing Type
 
Interest Rate
 
Maturity (1)
 
Amortization Date (1)
 
Available Borrowing Capacity (2)
 
September 30, 2015
 
December 31, 2014
Ocwen Freddie Servicer Advance Receivables Trust Series 2012-ADV1 (4)
 
1ML (3) + 175 bps
 
Jun. 2017
 
Jun. 2015
 
$

 
$

 
$
373,080

Ocwen Servicer Advance Funding (SBC) Note (5)
 
1ML + 300 bps
 
Dec. 2015
 
Dec. 2014
 

 

 
494

Advance Receivables Backed Notes, Series 2013-VF2,
Class A (6)
 
Cost of Funds + 191 bps
 
Oct. 2045
 
Oct. 2015
 

 

 
519,634

Advance Receivables Backed Notes, Series 2013-VF2,
Class B (6)
 
Cost of Funds + 343 bps
 
Oct. 2045
 
Oct. 2015
 

 

 
32,919

Advance Receivables Backed Notes - Series 2014-VF3,
Class A (7)
 
1ML + 235 bps (7)
 
Sep. 2046
 
Sep. 2016
 
100,547

 
263,244

 
552,553

Borrowing Type
 
Interest Rate
 
Maturity (1)
 
Amortization Date (1)
 
Available Borrowing Capacity (2)
 
September 30, 2015
 
December 31, 2014
Advance Receivables Backed Notes - Series 2014-VF3,
Class B (7)
 
1ML + 300 bps (7)
 
Sep. 2046
 
Sep. 2016
 
4,604

 
12,551

 

Advance Receivables Backed Notes - Series 2014-VF3,
Class C (7)
 
1ML + 425 bps (7)
 
Sep. 2046
 
Sep. 2016
 
5,154

 
13,825

 

Advance Receivables Backed Notes - Series 2014-VF3,
Class D (7)
 
1ML + 575 bps (7)
 
Sep. 2046
 
Sep. 2016
 
13,572

 
36,503

 

Advance Receivables Backed Notes - Series 2014-VF4, Class A (8)
 
1ML + 235 bps (8)
 
Sep. 2046
 
Sep. 2016
 
100,547

 
263,244

 
552,553

Advance Receivables Backed Notes - Series 2014-VF4, Class B (8)
 
1ML + 300 bps (8)
 
Sep. 2046
 
Sep. 2016
 
4,604

 
12,551

 

Advance Receivables Backed Notes - Series 2014-VF4, Class C (8)
 
1ML + 425 bps (8)
 
Sep. 2046
 
Sep. 2016
 
5,154

 
13,825

 

Advance Receivables Backed Notes - Series 2014-VF4, Class D (8)
 
1ML + 575 bps (8)
 
Sep. 2046
 
Sep. 2016
 
13,572

 
36,503

 

Advance Receivables Backed Notes - Series 2015-VF5, Class A (9)
 
1ML + 235 bps (9)
 
Sep. 2046
 
Sep. 2016
 
100,548

 
263,243

 

Advance Receivables Backed Notes - Series 2015-VF5, Class B (9)
 
1ML + 300 bps (9)
 
Sep. 2046
 
Sep. 2016
 
4,604

 
12,551

 

Advance Receivables Backed Notes - Series 2015-VF5, Class C (9)
 
1ML + 425 bps (9)
 
Sep. 2046
 
Sep. 2016
 
5,154

 
13,825

 

Advance Receivables Backed Notes - Series 2015-VF5, Class D (9)
 
1ML + 575 bps (9)
 
Sep. 2046
 
Sep. 2016
 
13,572

 
36,503

 

Advance Receivables Backed Notes - Series 2015-T1, Class A (9)
 
2.5365%
 
Sep. 2046
 
Sep. 2016
 

 
244,809

 

Advance Receivables Backed Notes - Series 2015-T1, Class B (9)
 
3.0307%
 
Sep. 2046
 
Sep. 2016
 

 
10,930

 

Advance Receivables Backed Notes - Series 2015-T1, Class C (9)
 
3.5240%
 
Sep. 2046
 
Sep. 2016
 

 
12,011

 

Advance Receivables Backed Notes - Series 2015-T1, Class D (9)
 
4.1000%
 
Sep. 2046
 
Sep. 2016
 

 
32,250

 

Total Ocwen Master Advance Receivables Trust (OMART)
 
 
 
 
 
 
 
371,632

 
1,278,368

 
1,657,659

Advance Receivables Backed Notes, Series 2014-VF1,
Class A
 
Cost of Funds + 275 bps
 
Dec. 2045
 
Dec. 2015
 
6,762

 
16,548

 
21,192

Advance Receivables Backed Notes, Series 2014-VF1,
Class B
 
Cost of Funds + 325 bps
 
Dec. 2045
 
Dec. 2015
 
11,482

 
10,918

 
13,598

Borrowing Type
 
Interest Rate
 
Maturity (1)
 
Amortization Date (1)
 
Available Borrowing Capacity (2)
 
September 30, 2015
 
December 31, 2014
Advance Receivables Backed Notes, Series 2014-VF1,
Class C
 
Cost of Funds + 375 bps
 
Dec. 2045
 
Dec. 2015
 
8,920

 
8,230

 
10,224

Advance Receivables Backed Notes, Series 2014-VF1,
Class D
 
Cost of Funds + 470 bps
 
Dec. 2045
 
Dec. 2015
 
13,366

 
11,274

 
14,000

Total Ocwen Servicer Advance Receivables Trust III (OSARTIII) (10)
 
 
 
 
 
 
 
40,530

 
46,970

 
59,014

Advance Receivables Backed Notes, Series 2015-VF1,
Class A
 
1ML + 212.5 bps
 
Jun. 2046
 
Jun. 2016
 
22,661

 
159,539

 

Advance Receivables Backed Notes, Series 2015-VF1,
Class B
 
1ML + 300 bps
 
Jun. 2046
 
Jun. 2016
 
3,354

 
15,946

 

Advance Receivables Backed Notes, Series 2015-VF1,
Class C
 
1ML + 350 bps
 
Jun. 2046
 
Jun. 2016
 
2,026

 
7,874

 

Advance Receivables Backed Notes, Series 2015-VF1,
Class D
 
1ML + 425 bps
 
Jun. 2046
 
Jun. 2016
 
2,451

 
11,149

 

Advance Receivables Backed Notes, Series 2015-T1,
Class A
 
2.062%
 
Nov. 2045
 
Nov. 2015
 

 
57,100

 

Advance Receivables Backed Notes, Series 2015-T1,
Class B
 
2.557%
 
Nov. 2045
 
Nov. 2015
 

 
5,400

 

Advance Receivables Backed Notes, Series 2015-T1,
Class C
 
3.051%
 
Nov. 2045
 
Nov. 2015
 

 
1,900

 

Advance Receivables Backed Notes, Series 2015-T1,
Class D
 
3.790%
 
Nov. 2045
 
Nov. 2015
 

 
5,600

 

Total Ocwen Freddie Advance Funding Facility (OFAF) (11)
 
 
 
 
 
 
 
30,492

 
264,508

 

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
442,654

 
$
1,589,846

 
$
2,090,247

 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average interest rate
 
 
 
 
 
 
 
 
 
2.91
%
 
1.97
%
(1)
The amortization date of our advance financing facilities is the date on which the revolving period ends under each advance financing facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the date on which all outstanding balances must be repaid. In each of our advance facilities, there are multiple notes outstanding. For each note, after the amortization date, all collections that represent the repayment of advances pledged to the facility must be applied to reduce the balance of the note(s) outstanding, and any new advances are ineligible to be financed.
(2)
Borrowing capacity is available to us only to the extent that we have pledged collateral available to borrow against. At September 30, 2015, $176.9 million of the total borrowing capacity was available to us based on the amount of eligible collateral that had been pledged.
(3)
1-Month LIBOR (1ML) was 0.19% and 0.17% at September 30, 2015 and December 31, 2014, respectively.
(4)
We repaid this facility in full in June 2015 from the proceeds of the OFAF facility.
(5)
We voluntarily terminated this facility on January 15, 2015.
(6)
The Series 2013-VF2 Notes were repaid in full on September 18, 2015.
(7)
On September 18, 2015, the combined maximum borrowing capacity of Series 2014-VF3 Notes, a series of variable funding notes under our Ocwen Master Advance Receivables Trust (OMART) facility, was reduced to $450.0 million, and the Class B, C and D Notes were issued. There is a floor of 75 bps for 1 ML in determining the interest rate for variable rate Notes.
(8)
Effective July 1, 2015, the single outstanding Series 2014-VF4 Note under our OMART facility was replaced by four Notes - Class A, B, C and D. On September 18, 2015, the combined maximum borrowing capacity of the Series 2014-VF4 Notes was reduced to $450.0 million. There is a floor of 75 bps for 1 ML in determining the interest rate for variable rate Notes.
(9)
The Series 2015-VF5 Notes and the Series 2015-T1 Notes under our OMART facility were issued on September 18, 2015. Under the terms of the agreement, we must continue to borrow the full amount of the Series 2015-T1 Notes until the amortization date. If there is insufficient collateral to support the level of borrowing, the excess cash proceeds are not distributed to Ocwen but are held by the trustee, and interest expense continues to be based on the full amount of the term notes. There is a floor of 75 bps for 1 ML in determining the interest for variable rate Notes.
(10)
Effective April 23, 2015, the maximum borrowing under the Ocwen Servicer Advance Receivables Trust III (OSARTIII) facility decreases by $6.3 million per month until it is reduced to $75.0 million.
(11)
We entered into Ocwen Freddie Advance Funding Facility (OFAF) facility on June 10, 2015. Under the terms of the agreement, we must continue to borrow the full amount of the Series 2015-T1 and Series 2015-T2 Notes until the amortization date. If there is insufficient collateral to support the level of borrowing, the excess cash proceeds are not distributed to Ocwen but are held by the trustee, and interest expense continues to be based on the full amount of the term notes. The Series 2015-T2 Notes with a combined borrowing capacity of $155.0 million expired and were fully repaid on September 15, 2015.
Match funded liabilities are comprised of the following at December 31:
Borrowing Type
 
Interest Rate
 
Maturity (1)
 
Amortization Date (1)
 
Available Borrowing Capacity (2)
 
2014
 
2013
Advance Receivable Backed Notes Series 2012-ADV1 (3)
 
1-Month LIBOR (1ML) (4) + 175 bps
 
Jun. 2017
 
Jun. 2015
 
$
76,920

 
$
373,080

 
$
417,388

Advance Receivable Backed Note (5)
 
1ML + 300 bps
 
Dec. 2015
 
Dec. 2014
 
49,506

 
494

 
33,211

2012-Homeward Agency Advance Funding Trust
2012-1 (6)
 
Cost of Funds + 300 bps
 
Apr. 2014
 
Apr. 2014
 

 

 
21,019

Advance Receivables Backed Notes, Series 2013-VF1,
Class A (7)
 
1ML + 175 bps (7)
 
Oct. 2044
 
Oct. 2014
 

 

 
1,494,628

Advance Receivables Backed Notes, Series 2013-VF2,
Class A (8)
 
1ML + 167 bps (8)
 
Oct. 2045
 
Oct. 2015
 
44,366

 
519,634

 
385,645

Advance Receivables Backed Notes, Series 2013-VF2,
Class B (9)
 
1ML + 300 bps (9)
 
Oct. 2045
 
Oct. 2015
 
3,081

 
32,919

 
12,923

Advance Receivables Backed Notes, Series 2014-VF3,
Class A (10)
 
1ML + 175 bps (10)
 
Oct. 2045
 
Oct. 2015
 
47,447

 
552,553

 

Advance Receivables Backed Notes, Series 2014-VF4 (11)
 
1ML + 175 bps (11)
 
Oct. 2045
 
Oct. 2015
 
47,447

 
552,553

 

Advance Receivables Backed Notes, Series 2014-VF1,
Class A (12)
 
Cost of Funds + 275 bps
 
Dec. 2045
 
Dec. 2015
 
65,986

 
21,192

 

Advance Receivables Backed Notes, Series 2014-VF1,
Class B (12)
 
Cost of Funds + 325 bps
 
Dec. 2045
 
Dec. 2015
 

 
13,598

 

Advance Receivables Backed Notes, Series 2014-VF1,
Class C (12)
 
Cost of Funds + 375 bps
 
Dec. 2045
 
Dec. 2015
 

 
10,224

 

Advance Receivables Backed Notes, Series 2014-VF1,
Class D (12)
 
Cost of Funds + 470 bps
 
Dec. 2045
 
Dec. 2015
 

 
14,000

 

 
 
 
 
 
 
 
 
$
334,753

 
$
2,090,247

 
$
2,364,814

 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average interest rate
 
 
 
 
 
 
 
 
 
1.97
%
 
2.08
%
(1)
The amortization date of our facilities is the date on which the revolving period ends under each advance facility note and repayment of the outstanding balance must begin if the note is not renewed or extended. The maturity date is the date on which all outstanding balances must be repaid. In two advance facilities, there are multiple notes outstanding. For each note, after the amortization date, all collections that represent the repayment of advances pledged to the facility must be applied to reduce the balance of the note outstanding, and any new advances are ineligible to be financed.
(2)
Borrowing capacity is available to us provided that we have additional eligible collateral to pledge. Collateral may only be pledged to one facility. At December 31, 2014, none of the available borrowing capacity could be used based on the amount of eligible collateral that had been pledged.
(3)
On February 1, 2015, the borrowing capacity under this facility was reduced to $400.0 million.
(4)
1-Month LIBOR was 0.17% and 0.17% at December 31, 2014 and 2013, respectively.
(5)
We voluntarily terminated this advance facility on January 30, 2015.
(6)
Advance facility assumed as part of the acquisition of Homeward. This facility was terminated on April 16, 2014, and the advances pledged to the facility were transferred to another facility.
(7)
These notes were issued in connection with the OneWest MSR Transaction. On March 17, 2014, the maximum borrowing capacity under the 2013-VF1 note declined by $500.0 million to a total of $1.0 billion. On October 1, 2014, the 2013-VF1 note was fully repaid.
(8)
On October 1, 2014, the maximum borrowing capacity of the VF2, Class A notes was increased to $564.0 million. The interest margin on these notes was set at 167 bps and is scheduled to increase to 191 bps on July 15, 2015, to 215 bps on August 15, 2015 and 239 bps on September 15, 2015.
(9)
On October 1, 2014, the maximum borrowing capacity of the VF2, Class B notes was increased to $36.0 million. The interest margin on these notes was set at 300 bps and is scheduled to increase to 343 bps on July 15, 2015, to 386 bps on August 15, 2015 and 429 bps on September 15, 2015.
(10)
On October 1, 2014, the maximum borrowing capacity of the note was increased to $600.0 million. The interest margin was set at 175 bps and is scheduled to increase to 200 bps on July 15, 2015, to 225 bps on August 15, 2015 and to 250 bps on September 15, 2015.
(11)
The 2014-VF4 note was issued on October 1, 2014 with a maximum borrowing capacity of $600.0 million. The interest margin on this new series of notes was set at 175 bps and is scheduled to increase to 200 bps on July 15, 2015, to 212 bps on August 15, 2015 and to 250 bps on September 15, 2015.
(12)
The 2014-VF1 notes were issued on December 23, 2014. Maximum borrowing under the facility is $125.0 million. The maximum note balance for the Class A Note is $125.0 million less the actual borrowings under the Class B, C and D Notes. The maximum note balance for the Class B Note is $32.0 million, for the Class C Note $24.5 million and for the Class D note $32.5 million. Beginning April 23, 2015, the maximum borrowing under the facility will decrease by $6.3 million per month until it is reduced to $75.0 million.
Schedule of Financing Liabilities
Financing liabilities are comprised of the following at the dates indicated:
Borrowings
 
Collateral
 
Interest Rate
 
Maturity
 
September 30, 2015
 
December 31, 2014
Servicing:
 
 
 
 
 
 
 
 
 
 
Financing liability – MSRs pledged
 
MSRs
 
(1)
 
(1)
 
$
560,059

 
$
614,441

Secured Notes, Ocwen Asset Servicing Income Series, Series 2014-1 (2)
 
MSRs
 
(2)
 
Feb. 2028
 
100,000

 
111,459

Financing Liability – Advances Pledged (3)
 
Advances on loans
 
(3)
 
(3)
 
63,855

 
88,489

 
 
 
 
 
 
 
 
723,914

 
814,389

 
 
 
 
 
 
 
 
 
 
 
Lending:
 
 
 
 
 
 
 
 
 
 
HMBS-related borrowings (4)
 
Loans held for investment (LHFI)
 
1ML + 248 bps
 
(4)
 
2,229,604

 
1,444,252

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
2,953,518

 
$
2,258,641

(1)
This financing liability arose in connection with the NRZ/HLSS Transactions and has no contractual maturity. The balance of the liability is adjusted each reporting period to its fair value based on the present value of the estimated future cash flows underlying the related MSRs.
(2)
OASIS noteholders are entitled to receive a monthly payment amount equal to the sum of: (a) the designated servicing fee amount (21 basis points of the UPB of the reference pool of Freddie Mac mortgages); (b) any termination payment amounts; (c) any excess refinance amounts; and (d) the note redemption amounts, each as defined in the indenture supplement for the notes. The notes have a final stated maturity of February 2028. We accounted for this transaction as a financing. Monthly amortization of the liability is estimated using the proportion of monthly projected service fees on the underlying MSRs as a percentage of lifetime projected fees, adjusted for the term of the security.
(3)
Certain sales of advances in 2014 did not qualify for sales accounting treatment and were accounted for as a financing.
(4)
Represents amounts due to the holders of beneficial interests in Ginnie Mae guaranteed HMBS. The beneficial interests have no maturity dates, and the borrowings mature as the related loans are repaid.
Financing liabilities are comprised of the following at December 31:
Borrowings
 
Collateral
 
Interest Rate
 
Maturity
 
2014
 
2013
Servicing:
 
 
 
 
 
 
 
 
 
 
Financing liability – MSRs pledged
 
MSRs
 
(1)
 
(1)
 
$
614,441

 
$
633,804

Secured Notes, Ocwen Asset Servicing Income Series, Series 2014-1 (2)
 
MSRs
 
(2)
 
Feb. 2028
 
111,459

 

Financing liability – Advances pledged (3)
 
MSRs
 
(3)
 
(3)
 
88,489

 

 
 
 
 
 
 
 
 
814,389

 
633,804

 
 
 
 
 
 
 
 
 
 
 
Lending:
 
 
 
 
 
 
 
 
 
 
Financing liability - MSRs pledged (4)
 
MSRs
 
(4)
 
(4)
 

 
17,593

HMBS-related borrowings (5)
 
Loans held for investment
 
1ML + 243 bps
 
(5)
 
1,444,252

 
615,576

 
 
 
 
 
 
 
 
1,444,252

 
633,169

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
$
2,258,641

 
$
1,266,973

(1)
This financing liability arose in connection with the HLSS Transactions and has no contractual maturity. The balance of the liability is adjusted each reporting period to its fair value based on the present value of the estimated future cash flows underlying the related MSRs.
(2)
OASIS noteholders are entitled to receive a monthly payment amount equal to the sum of: (a) the designated servicing fee amount (21 basis points of the UPB of the reference pool of Freddie Mac mortgages); (b) any termination payment amounts; (c) any excess refinance amounts; and (d) the note redemption amounts, each as defined in the indenture supplement for the notes. The notes have a final stated maturity of February 2028. We accounted for this transaction as a financing. Monthly amortization of the liability is estimated using the proportion of monthly projected service fees on the underlying MSRs as a percentage of lifetime projected fees, adjusted for the term of the security.
(3)
Certain advances were sold to HLSS Mortgage and HLSS SEZ LP on March 4, 2014 and May 2, 2014, respectively. These sales of advances did not qualify for sales accounting treatment and were accounted for as a financing.
(4)
Represents sales of MSRs to a third party that were being accounted for as a financing. The financing liability was being amortized using the interest method with the servicing income that was remitted to the purchaser representing payments of principal and interest. In April 2014, we derecognized the remaining liability related to this MSR sale. During 2014, we recognized a gain of $2.6 million on the extinguishment of the financing liability.
(5)
Represents amounts due to the holders of beneficial interests in Ginnie Mae guaranteed HMBS. The beneficial interests have no maturity dates, and the borrowings mature as the related loans are repaid.
Schedule of Other Secured Borrowings
Other secured borrowings are comprised of the following at the dates indicated:
Borrowings
 
Collateral
 
Interest Rate
 
Maturity
 
Available Borrowing Capacity
 
September 30, 2015
 
December 31, 2014
Servicing:
 
 
 
 
 
 
 
 
 
 
 
 
SSTL (1)
 
(1)
 
1-Month Euro-dollar rate + 375 bps with a Eurodollar floor of 125 bps (1)
 
Feb. 2018
 
$

 
$
705,927

 
$
1,277,250

Master repurchase agreement (2)
 
Loans held for sale (LHFS)
 
1ML + 200 - 345 bps
 
Jul. 2016
 
23,871

 
26,129

 
32,018

 
 
 
 
 
 
 
 
23,871

 
732,056

 
1,309,268

 
 
 
 
 
 
 
 
 
 
 
 
 
Borrowings
 
Collateral
 
Interest Rate
 
Maturity
 
Available Borrowing Capacity
 
September 30, 2015
 
December 31, 2014
Lending:
 
 
 
 
 
 
 
 
 
 
 
 
Master repurchase agreement (3)
 
LHFS
 
1ML + 200 bps
 
Aug. 2016
 
68,618

 
131,382

 
208,010

Participation agreement (4)
 
LHFS
 
N/A
 
Apr. 2016
 

 
46,597

 
41,646

Participation agreement (5)
 
LHFS
 
N/A
 
Apr. 2016
 

 
33,864

 
196

Master repurchase agreement (6)
 
LHFS
 
1ML + 175 - 275 bps
 
Jul. 2015
 

 

 
102,073

Master repurchase agreement (7)
 
LHFI
 
1ML + 275bps
 
Jul. 2015
 

 

 
52,678

Mortgage warehouse agreement (8)
 
LHFI
 
1ML + 275 bps; floor of 350 bps
 
May 2016
 

 
60,180

 
23,851

 
 
 
 
 
 
 
 
68,618

 
272,023

 
428,454

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
92,489

 
1,004,079

 
1,737,722

Discount - SSTL
 
 
 
 
 
 
 

 
(3,009
)
 
(4,031
)
 
 
 
 
 
 
 
 
$
92,489

 
$
1,001,070

 
$
1,733,691

 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average interest rate
 
 
 
 
 
 
 
 
 
4.42
%
 
4.33
%
(1)
The borrowings are secured by a first priority security interest in substantially all of the assets of Ocwen. Borrowings bear interest, at the election of Ocwen, at a rate per annum equal to either (a) the base rate (the greatest of (i) the prime rate in effect on such day, (ii) the federal funds rate in effect on such day plus 0.50% and (iii) the one-month Eurodollar rate (1-Month LIBOR)), plus a margin of 2.75% and subject to a base rate floor of 2.25% or (b) the one month Eurodollar rate, plus a margin of 3.75% and subject to a one month Eurodollar floor of 1.25%. To date we have elected option (b) to determine the interest rate.
On October 16, 2015, we entered into an amendment to the SSTL facility agreement pursuant to which, among other things, the Eurodollar margin was increased from 3.75% to 4.25%, effective October 20, 2015. See Note 21 – Subsequent Events for additional information.
(2)
On September 30, 2015, this repurchase agreement was renewed through September 29, 2016. Under this repurchase agreement, the lender provides financing on a committed basis for $50.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $50.0 million.
(3)
On August 25, 2015, this repurchase agreement was renewed through August 23, 2016. Borrowing capacity was reduced from $300.0 million, of which $150.0 million was provided on an uncommitted basis, to $200.0 million all of which is provided on a committed basis.
(4)
Under this participation agreement, the lender provides financing for $100.0 million at the discretion of the lender. The participation agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. The transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing. The lender earns the stated interest rate of the underlying mortgage loans while the loans are financed under the participation agreement.
(5)
Under this participation agreement, the lender provides financing for $150.0 million at the discretion of the lender. The participation agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. The transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing. The lender earns the stated interest rate of the underlying mortgage loans while the loans are financed under the participation agreement.
(6)
On April 16, 2015, this facility was voluntarily terminated.
(7)
This facility was allowed to expire.
(8)
Borrowing capacity of $100.0 million under this facility is available at the discretion of the lender. This facility was renewed on August 24, 2015, and the borrowing capacity was increased from $60.0 million to $100.0 million.
Other secured borrowings are comprised of the following at December 31:
Borrowings
 
Collateral
 
Interest Rate
 
Maturity
 
Available Committed Borrowing Capacity
 
2014
 
2013
Servicing:
 
 
 
 
 
 
 
 
 
 
 
 
SSTL (1)
 
(1)
 
1-Month Euro-dollar rate + 375 bps with a Eurodollar floor of 125 bps (1)
 
Feb. 2018
 
$

 
$
1,277,250

 
$
1,290,250

Promissory note (2)
 
MSRs
 
1ML + 350 bps
 
May 2017
 

 

 
15,529

Repurchase agreement (3)
 
Loans held for sale (LHFS)
 
1ML + 200 - 345 bps
 
Jun. 2015
 
17,982

 
32,018

 
17,507

 
 
 
 
 
 
 
 
17,982

 
1,309,268

 
1,323,286

 
 
 
 
 
 
 
 
 
 
 
 
 
Lending:
 
 
 
 
 
 
 
 
 
 
 
 
Master repurchase agreement (4)
 
LHFS
 
1ML + 175 bps
 
Jun. 2015
 

 
208,010

 
105,659

Participation agreement (5)
 
LHFS
 
N/A
 
Apr. 2016
 

 
41,646

 
81,268

Participation agreement (6)
 
LHFS
 
N/A
 
Apr. 2016
 

 
196

 

Master repurchase agreement (7)
 
LHFS
 
1ML + 175 - 275 bps
 
Jul. 2015
 

 
102,073

 
91,990

Master repurchase agreement (8)
 
LHFS
 
1ML + 175 - 200 bps
 
Nov. 2014
 

 

 
89,836

Master repurchase agreement (9)
 
LHFS
 
1ML + 275bps
 
Jul. 2015
 

 
52,678

 
51,975

Mortgage warehouse agreement (10)
 
LHFS
 
1ML + 275 bps; floor of 350 bps
 
May 2015
 

 
23,851

 
34,292

 
 
 
 
 
 
 
 

 
428,454

 
455,020

 
 
 
 
 
 
 
 
 
 
 
 
 
Corporate Items and Other:
 
 
 
 
 
 
 
 
 
 
 
 
Securities sold under an agreement to repurchase (11)
 
Ocwen Real Estate Asset Liquidating Trust 2007-1 Notes
 
Class A-2 notes: 1ML + 200 bps; Class A-3 notes: 1ML + 300 bps
 
Monthly
 

 

 
4,712

 
 
 
 
 
 
 
 
17,982

 
1,737,722

 
1,783,018

Discount (1)
 
 
 
 
 
 
 

 
(4,031
)
 
(5,349
)
 
 
 
 
 
 
 
 
$
17,982

 
$
1,733,691

 
$
1,777,669

 
 
 
 
 
 
 
 
 
 
 
 
 
Weighted average interest rate
 
 
 
 
 
 
 
 
 
4.33
%
 
4.86
%
(1)
On February 15, 2013, we entered into a new SSTL facility agreement and borrowed $1.3 billion that was used principally to fund the ResCap Acquisition and repay the balance of the previous SSTL. The loan was issued with an original issue discount of $6.5 million that we are amortizing over the term of the loan. We are required to repay the principal amount of the borrowings in consecutive quarterly installments of $3.3 million. In addition, we are generally required to use the net cash proceeds (as defined) from any asset sale (as defined) to repay loan principal. Generally, this provision applies to non-operating sales of assets, and net cash proceeds represent the proceeds from the sale of the assets, net of the repayment of any debt secured by a lien on the assets sold. However, for asset sales that are part of an HLSS Transaction, we have the option, within 180 days, either to invest the net cash proceeds in MSRs or related assets, such as advances, or to repay loan principal. The borrowings are secured by a first priority security interest in substantially all of the assets of Ocwen. Borrowings bear interest, at the election of Ocwen, at a rate per annum equal to either (a) the base rate [the greatest of (i) the prime rate in effect on such day, (ii) the federal funds rate in effect on such day plus 0.50% and (iii) the one-month Eurodollar rate (1-Month LIBOR)], plus a margin of 2.75% and a base rate floor of 2.25% or (b) the one month Eurodollar rate, plus a margin of 3.75% and a one month Eurodollar floor of 1.25%. To date we have elected option (b) to determine the interest rate.
On September 23, 2013, we entered into Amendment No. 1 to the Senior Secured Term Loan Facility Agreement and Amendment No. 1 to the related Pledge and Security Agreement. These amendments:
permit repurchases of all of the Preferred Shares, which may be converted to common stock prior to repurchase, and up to $1.5 billion of common stock, subject, in each case, to pro forma financial covenant compliance;
eliminate the dollar cap on Junior Indebtedness (as defined in the SSTL) but retain the requirement for any such issuance to be subject to pro forma covenant compliance;
include a value for whole loans (i.e., loans held for sale) in collateral value for purposes of calculating the loan-to-value ratio and include specified deferred servicing fees and the fair value of specified mortgage servicing rights in net worth for purposes of calculating the ratio of consolidated total debt to consolidated tangible net worth; and
modify the applicable quarterly covenant levels for the corporate leverage ratio, ratio of consolidated total debt to consolidated tangible net worth and loan-to-value ratio.
On March 2, 2015 and April 17, 2015, respectively, we entered into Amendments No. 2 and No. 3 to the Senior Secured Term Loan Facility Agreement. See Note 30 — Subsequent Events for additional information regarding these amendments.
(2)
This note was repaid in full on February 28, 2014.
(3)
Under this repurchase agreement, the lender provides financing on a committed basis for $50.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $50.0 million. On June 30, 2014, the maturity date of this facility was extended to June 29, 2015.
(4)
Under this repurchase agreement, the lender provides financing on a committed basis for $150.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $150.0 million. On April 17, 2014, the maturity date of this facility was extended to April 16, 2015. On March 24, 2015, the maturity date of this facility was further extended to June 10, 2015.
(5)
Under this participation agreement, the lender provides financing on an uncommitted basis for $100.0 million at the discretion of the lender. The participation agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. However, the transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing. The lender earns the stated interest rate of the underlying mortgage loans while the loans are financed under the participation agreement. On May 31, 2014, the maturity date of this facility was extended to May 31, 2015. On March 10, 2015, the maturity date of this agreement was further extended to April 30, 2016, and the maximum borrowing was reduced to $50.0 million. On April 16, 2015, the maximum borrowing capacity was increased to $100.0 million.
(6)
On November 12, 2014, we entered into this participation agreement under which the lender provides financing on an uncommitted basis up to $100.0 million at the discretion of the lender. The participation agreement allows the lender to acquire a 100% beneficial interest in the underlying mortgage loans. However, the transaction does not qualify for sale accounting treatment and is accounted for as a secured borrowing. The lender earns the stated interest rate of the underlying mortgage loans while the loans are financed under the participation agreement. On March 10, 2015, the maturity date of this agreement was extended to April 30, 2016, and the maximum borrowing was increased to $150.0 million.
(7)
Under this repurchase agreement, the lender provides financing on a committed basis for $75.0 million and, at the discretion of the lender, on an uncommitted basis for an additional $75.0 million. On September 2, 2014, the maturity date of this facility was extended to October 2, 2014. On October 2, 2014, the maturity date was further extended to September 1, 2015. On March 31, 2015, the maturity date was revised to July 31, 2015, and the committed lending capacity was to decline to zero on May 29, 2015. On April 16, 2015, this facility was terminated.
(8)
On October 24, 2014, this facility was repaid in full and terminated.
(9)
On September 2, 2014, the maximum borrowing capacity under this facility was reduced to $37.5 million on a committed basis plus an additional $37.5 million on an uncommitted basis at the discretion of the lender. On December 31, 2014, the termination date of this facility was extended to January 16, 2015. On January 16, 2015, the termination date was further extended to April 16, 2015. On March 31, 2015, the maturity date was further extended to July 31, 2015; however, the committed lending capacity declines to zero on May 29, 2015. On April 16, 2015, the maximum borrowing capacity under this agreement was reduced to $37.5 million, all of which is committed.
(10)
Borrowing capacity under this facility of $60.0 million is available on an uncommitted basis at the discretion of the lender. In August 2014, the maturity date of this facility was extended to May 28, 2015.
(11)
This agreement was terminated December 12, 2014.
Schedule of Redemption Prices  
The redemption prices during the twelve-month periods beginning on May 15th of each year are as follows:
Year
 
Redemption Price
2016
 
104.969%
2017
 
103.313%
2018 and thereafter
 
100.000%
Schedule of Aggregate Long-term Borrowings  
Aggregate long-term borrowings by maturity date at December 31, 2014 are as follows:
 
 
Expected Maturity Date (1) (2)
 
 
 
 
 
 
2015
 
2016
 
2017
 
2018
 
2019
 
There- after
 
Total
Balance
 
Fair
Value
Match funded liabilities
 
$
2,090,247

 
$

 
$

 
$

 
$

 
$

 
$
2,090,247

 
$
2,090,247

Other secured borrowings
 
472,160

 
11,701

 
11,714

 
1,238,116

 

 

 
1,733,691

 
1,658,699

Senior unsecured notes
 

 

 

 

 
350,000

 

 
350,000

 
321,563

 
 
$
2,562,407

 
$
11,701

 
$
11,714

 
$
1,238,116

 
$
350,000

 
$

 
$
4,173,938

 
$
4,070,509

(1)
For match funded liabilities, the expected maturity date is the date on which the revolving period ends for each advance financing facility note and repayment of the outstanding balance must begin if the note is not renewed or extended.
(2)
Excludes financing liabilities, which we recognized in connection with the sales transactions that we accounted for as financings. Financing liabilities include $614.4 million recorded in connection with sales of MSRs and Rights to MSRs and $1.4 billion recorded in connection with the securitizations of HMBS. The MSR-related financing liabilities have no contractual maturity and are amortized over the life of the transferred Rights to MSRs. The HMBS-related financing liabilities have no contractual maturity and are amortized as the related loans are repaid.